ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OliX, Hansoh Ink Licensing Pact To Deve
Generics BulletinChinese biosimilars developer Bio-Thera Solutions has announced plans to develop “novel oral monoclonal antibody treatments for chronic gastrointestinal inflammatory diseases,” after striking a deal